a new use of a zinc tranexamate compound in the treatment of diabetes is disclosed . oral administration of the compound adequately slows down absorption of glucose from digestive tracts by inhibiting α - glucosidase in vivo . the zinc tranexamate compound is also effective in the treatment of insulin - resistant type ii diabetes .